Fetal Growth versus Birthweight: The Role of Placenta versus Other Determinants by Roland, Marie Cecilie Paasche et al.
Fetal Growth versus Birthweight: The Role of Placenta
versus Other Determinants
Marie Cecilie Paasche Roland
1*, Camilla M. Friis
1, Nanna Voldner
1, Kristin Godang
2, Jens Bollerslev
2,3,
Guttorm Haugen
1,3, Tore Henriksen
1,3
1Department of Obstetrics, Oslo University Hospital, Oslo, Norway, 2Department of Specialized Endocrinology, Oslo University Hospital, Oslo, Norway, 3University of
Oslo, Oslo, Norway
Abstract
Introduction: Birthweight is used as an indicator of intrauterine growth, and determinants of birthweight are widely
studied. Less is known about determinants of deviating patterns of growth in utero. We aimed to study the effects of
maternal characteristics on both birthweight and fetal growth in third trimester and introduce placental weight as a possible
determinant of both birthweight and fetal growth in third trimester.
Methods: The STORK study is a prospective cohort study including 1031 healthy pregnant women of Scandinavian heritage
with singleton pregnancies. Maternal determinants (age, parity, body mass index (BMI), gestational weight gain and fasting
plasma glucose) of birthweight and fetal growth estimated by biometric ultrasound measures were explored by linear
regression models. Two models were fitted, one with only maternal characteristics and one which included placental
weight.
Results: Placental weight was a significant determinant of birthweight. Parity, BMI, weight gain and fasting glucose
remained significant when adjusted for placental weight. Introducing placental weight as a covariate reduced the effect
estimate of the other variables in the model by 62% for BMI, 40% for weight gain, 33% for glucose and 22% for parity.
Determinants of fetal growth were parity, BMI and weight gain, but not fasting glucose. Placental weight was significant as
an independent variable. Parity, BMI and weight gain remained significant when adjusted for placental weight. Introducing
placental weight reduced the effect of BMI on fetal growth by 23%, weight gain by 14% and parity by 17%.
Conclusion: In conclusion, we find that placental weight is an important determinant of both birthweight and fetal growth.
Our findings indicate that placental weight markedly modifies the effect of maternal determinants of both birthweight and
fetal growth. The differential effect of third trimester glucose on birthweight and growth parameters illustrates that
birthweight and fetal growth are not identical entities.
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Introduction
Birthweight is associated with long term effects on health and
disease in adult life. Low birthweight is a well established risk
factor for adverse long term health, particularly cardiovascular
disease and metabolic syndrome [1]. Numerous studies have
identified determinants of abnormal birthweight, particularly low
birthweight, but also more recently of high birthweight [2–4].
Birthweight is used as an indicator of intrauterine growth. The
actual pattern of growth in utero can, however, only be estimated
by serial ultrasound measurements during pregnancy. Far less is
known about determinants of deviating patterns of growth in utero
than that of abnormal birthweights. Fetal growth is a result of
multiple factors including genetic potential for growth, maternal
nutrition, maternal metabolism, endocrine factors and placental
perfusion and function [5]. In addition, the ability of the fetus to
respond to nutrients and other growth regulatory factors may play
a role.
The Hyperglycaemia and Adverse Pregnancy Outcomes study
(HAPO) has established maternal blood glucose and body mass
index (BMI) as independent determinants of large for gestational
age (LGA) newborns and excessive body fat at birth [6,7]. It is
implicative in these findings that maternal plasma glucose and
other not specified biological factors associated with maternal BMI
affect fetal growth and neonatal body composition. The biological
mechanisms underlying the effect of glucose on fetal growth are
best explained by the Pedersen hypothesis [8]. Pedersen postulated
that maternal hyperglycemia was transferred to the fetus, which, in
turn, produced and released large amounts of insulin, with fetal
hyperinsulinemia as a result. However, the independent effect of
BMI is not well explained by any hypotheses that consistently fit
observations to the extent that the Pedersen hypothesis does.
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growth besides glucose and other BMI-related factors. Placental
function includes both transport capacity as well as endocrine and
metabolic properties. In principle maternal factors may affect fetal
growth via two main pathways. One may operate independently of
placenta, i.e. maternal nutrients and other factors enter the fetal
circulation directly without any interference from placental tissues.
The second pathway affects fetal growth indirectly by modifying
placental nutritional transport and metabolism. These two
principles are not mutually exclusive. A large number of studies
have investigated factors that may affect specific transport
mechanisms in placenta, like transfer of glucose, amino acids
and fatty acids [9–11]. These studies provide strong evidence that
placental function (i.e. ability to provide and regulate nutrient
supply to the fetus) is modified by both maternal and fetal factors.
However, in most clinical and epidemiological investigations like
the HAPO–study, the role of placenta has not been specifically
addressed. One problem of including placenta is that there is no
specific marker that reflects the overall placental function.
However, the capacity for nutrient transfer is reflected in the
surface area for transport and hence the placental size [12].
Placental weight is a crude marker of placental size, but correlates
closely to birthweight in normal pregnancies [13]. Placental weight
is widely used as a parameter of placental functional capacity.
The aims of this study were to.
1) Estimate and compare the effects of maternal characteristics
on both birthweight and fetal growth in third trimester.
2) Introduce placental weight as a possible determinant of both
birthweight and fetal growth in third trimester.
Methods
Ethics Statement
Written informed consent was obtained from all participants in
the study. All clinical investigations were conducted according to
the principles expressed in the Declaration of Helsinki. The study
was approved by the Regional Committee for Medical Research
Ethics, Southern Norway, Oslo, Norway (S-01191).
Population
The STORK study is a prospective cohort study performed in
the period 2001–2008. A total of 1031 healthy pregnant women
who gave birth at Oslo University Hospital, Rikshospitalet,
Norway were included in the study (Figure 1). Study design and
data from the first 553 women included in the study have been
published [2–4]. Inclusion criteria were healthy women of
Scandinavian heritage with singleton pregnancies. Exclusion
criteria were multiple pregnancies, known pre-gestational diabetes
and any severe chronic diseases (lung, cardiac, gastrointestinal or
renal). Each pregnant woman had four antenatal visits (visit 1–4),
scheduled at weeks 14–16, 22–24, 30–32 and 36–38 of pregnancy.
Clinical data and fasting blood samples were collected at each visit.
Ultrasound examinations were done at all visits, except the first.
Independent Variables
Five variables known to influence birthweight were selected
based on previous literature and published data on birthweight
from the STORK study [2]. The selected variables were maternal
age, parity, BMI, gestational weight gain and fasting plasma
glucose. In addition placental weight was included as a potential
determinant of birthweight and fetal growth.
The same variables were used in all models for comparison.
BMI (kg/m
2) was calculated by height and weight. Maternal
height was measured at the first visit and weight was measured by
a calibrated scale at each visit. Gestational weight gain was
calculated as the difference between weights measured at visit 4
and visit 1. Measured weight at the first visit was used instead of
pre pregnancy weight to avoid false self reporting of pre pregnancy
weight. Fasting plasma glucose was measured at weeks 30–32, by
Accucheck (Roche Diagnostics, Mannheim, Germany). Due to an
unexpected increasing trend in fasting plasma glucose of
0.6 mmol/l over time, the glucose values were adjusted statistically
[14]. It was essential to explore to which extent the trend was of
biological or analytical origin. The lack of a corresponding
increase in the women’s body mass index, insulin or age, made it
unlikely that the observed trend in blood glucose values could have
a biological cause, or be due to selection bias. Thus the time trend
in fasting glucose most likely had an analytical cause. Briefly, linear
regression gave estimates for the average increase per time unit,
under the assumption of a linear increase during the entire period.
The glucose values were de-trended according to the coefficients
from the linear regression and de-trending of the data removed the
increasing trend.
Data on age, parity, obstetric history, educational level and
smoking status were registered. Parity was coded as P0 for
primigravida and P1 for one or more previous births. Gestational
age was based on ultrasound biometric measures made at weeks
17–19. Placental weight including umbilical cord and membranes
was measured by the midwife attending the delivery within an
hour after delivery.
Dependent Variables
Both birthweight and estimated fetal growth in third trimester
were used as dependent variables. Birthweight was measured by
a calibrated scale. Birthweight is given as birthweight for
gestational age and sex-specific z-scores [15]. Fetal growth in
third trimester was estimated by serial ultrasound measurements.
Ultrasound examination was done three times, scheduled at weeks
22–24, weeks 30–32 and weeks 36–38. Each ultrasound exami-
nation included fetal biometric parameters. Head circumference
(HC), abdominal circumference (AC) and femur length (FL) were
measured three times at each visit and the mean value was
Figure 1. Flow-chart showing the inclusion and exclusion of
women in the study.
doi:10.1371/journal.pone.0039324.g001
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Acuson Aspen ultrasound machine. Estimated fetal weight (EFW)
was calculated by Combs formula [16]. Estimated fetal weight in
accurate percentiles were calculated according to Norwegian
charts developed in Bergen, Norway [17]. Fetal growth in third
trimester was chosen as this period is one of rapid fetal growth and
fat accumulation, and also the period when metabolic, modifiable
factors are most likely to influence fetal growth and fat
accumulation [18].
Fetal growth between visit 3 and visit 4 in third trimester was
calculated in two ways;
1) The difference in estimated fetal weight percentiles (Dp)
according to Norwegian reference charts [17], calculated by
Combs formula.
2) The difference in abdominal circumference (ACDz), head
circumference (HCDz) or femur length (FLDz) separately.
The differences were calculated as differences in z-scores,
according to Norwegian reference charts [19].
Statistical Analysis
Descriptive statistics are presented as mean and standard
deviation (SD) and frequency and percentage (%). Maternal
determinants for birthweight were explored by univariate and
multiple linear regression models. Two models were fitted, one
which included only maternal characteristics and one which
included the same covariates but adding placental weight.
Variables with p-values ,0.1 in the univariate analyses were
considered in the multiple models. The same approach was used
to explore the associations between maternal characteristics and
fetal growth in third trimester. A p-value ,0.05 was considered
statistically significant. All analyses were done using the Statistical
Package for Social Sciences (SPSS version 18.0) for Windows
(SPSS Inc., Chicago, IL).
Results
Study Population
Demographic and clinical characteristics of the cohort are
shown in Table 1. The cohort consisted of 1031 women and their
newborns. Mean maternal age was 31.3 years (SD 3.9), 52.9%
were primiparous and only 2.7% of the participants were daily
smokers during pregnancy. Mean birthweight was 3588 grams
(SD 574) and mean gestational age at delivery was 39.5 weeks (SD
1.8, range 26–43 weeks). The study population was comparable to
women who gave birth in Oslo on parameters like birthweight,
parity, maternal age and gestational age at birth [20].
Birthweight
We first examined the association between selected and well
known maternal determinants and birthweight. Table 2 shows the
variables that were associated with birthweight for gestational age
Z-score. The first model did not include placental weight as
a covariate.
In the multiple model parity (B 0.46, 95% CI 0.33–0.59,
p,0.001), BMI (B 0.048, 95% CI 0.03–0.06, p,0.001), weight
gain (B 0.06, 95% CI 0.04–0.08, p,0.001) and fasting glucose (B
0.33, 95% CI 0.18–0.48, p,0.001) remained statistically signifi-
cant determinants of birthweight, whereas maternal age was not
significant (B 0.00, 95% CI 20.02–0.02, p=0.98). In the model
including placental weight as a covariate, placental weight was
statistically significant both in the univariate (B 0.41, 95% CI
0.38–0.44, p,0.001) and multiple models (B 0.39, 95% CI 0.35–
0.42, p,0.001). In addition, parity (B 0.36, 95% CI 0.25–0.47,
p,0.001), BMI (B 0.018, 95% CI 0.004–0.03, p=0.012), weight
gain (B 0.036, 95% CI 0.02–0.05, p,0.001) and fasting plasma
glucose (B 0.22, 95% CI 0.09–0.34, p,0.001) remained significant
determinants when adjusted for placental weight.
Introducing placental weight as a covariate reduced the effect
estimate of the other variables in the model. The magnitude of
reduction as estimated by change in the regression coefficient B of
the linear regression was 62% for BMI, 40% for weight gain, 33%
for glucose and 22% for parity.
Fetal Growth
Table 3 shows the biometric parameters based on ultrasound
measurements at visit 3 and 4, from which fetal growth was
estimated. Each measurement is given both in mm and the
corresponding z-score for gestational age. In addition, the
percentiles of weight estimates are given. Fetal growth between
visit 3 and visit 4 was estimated both as difference in percentiles
(Dp) and in z-score for each biometric measurement (HCDz,
ACDz and FLDz).
Table 4 shows the results of the linear regression analyses when
fetal growth in third trimester was estimated as differences in
estimated fetal weight percentiles between visit 3 and visit 4.
Univariate analyses showed that parity (B 4.35, 95% CI 1.29–7.41,
p=0.005), BMI (B 0.71, 95% CI 0.32–1.11, p,0.001) and weight
gain (B 0.62, 95% CI 0.17–1.07, p=0.007) were statistically
significant, whereas maternal age (B 0.11, 95% CI 20.29–0.50,
p=0.6) and fasting glucose (B 2.55, 95% CI 0.89–5.99, p=0.15)
were not significant. In the multiple model parity (B 4.73, 95% CI
0.16–8.07, p=0.006), BMI (B 0.64, 95% CI 0.23–1.06, p=0.002)
Table 1. Clinical and demographic characteristics of the
mothers and babies.
n Mean (SD) % Range
Mothers 1031
Age (years) 31.3 (3.9) 19–42
Para 0 545 52.9
BMI visit 1 24.5 (3.9) 17.2–43.9
Weight gain (kg) visit 4–1 10.6 (3.5) 21.2–
29.4
Married or partnership 1011 98.1
Higher education ($15 years) 885 85.8
Daily smoking 28 2.7
Fasting plasma glucose visit
3 (mmol/l)
4.1 (0.45) 2.9–6.2
Gestational diabetes * 56 5.5
Preeclampsia ** 39 3.8
Babies
Sex (boys) 548 53.1
Gestational age at birth (weeks) 39.5 (1.8) 26–43
Birthweight (g) 3588 (574) 600–
5420
Placental weight (g) 711 (156) 220–
1490
*According to WHO-criteria: Plasma glucose $7.8 mmol/l 2 hours after an Oral
glucose tolerance test of 75 g of glucose.
**Blood pressure $140/90 mmHg combined with proteinuria (urinary
totalprotein/creatine ratio .30 or +1 on urine dipstick).
doi:10.1371/journal.pone.0039324.t001
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significant. When placental weight was included, parity (B 3.9,
95% CI 0.75–7.0, p=0.015), BMI (B 0.49, 95% CI 0.08–0.89,
p=0.02), weight gain (B 0.60, 95% CI 0.15–1.06, p=0.01) and
placental weight (B 2.08, 95% CI 1.03–3.13, p,0.001) remained
significant, also in the multiple model. Introducing placental
weight reduced the effect of BMI on fetal growth by 23%, weight
gain by 14% and parity by 17%, as estimated by change in B.
Finally, we analysed the effects of the selected characteristics on
fetal growth made on each of the fetal biometric measures.
Abdominal Circumference
Table 5 shows the effects of determinants on the growth of the
abdominal circumference between visit 3 and visit 4. In the
univariate analyses all variables except maternal age were
significant. In the multiple model parity (B 0.18, 95% CI 0.07–
0.29, p=0.001), BMI (B 0.022, 95% CI 0.005–0.03, p=0.002)
and weight gain (B 0.026, 95% CI 0.008–0.04, p=0.001)
remained statistically significant, whereas fasting glucose (B
0.044, 95% CI 20.08–0.17, p=0.48) no longer was a statistically
significant independent variable for increase in abdominal
circumference. Including placental weight to the model showed
that placental weight was a significant determinant (B 0.095, 95%
CI 0.06–0.13, p,0.001). In the multiple model fasting plasma
glucose was not significant (B 0.016, 95% CI 20.11–0.14, p=0.8).
BMI reached borderline significance (B 0.014, 95% CI 0.00–
0.028, p=0,048) as an independent determinant when adjusted
for parity, weight gain and placental weight. For growth of the
fetal abdominal circumference BMI showed the largest reduction
in B (36%) when placental weight was included.
Head Circumference and Femur Length
In univariate analyses of HCDz only BMI was a significant
determinant. For FLDz placental weight was the only significant
determinant (data not shown).
Discussion
The current study has two main findings. First, we show that
parity, BMI and weight gain, but not fasting glucose, were
significant determinants of intrauterine growth in third trimester,
both when calculated as a composite consisting of fetal head,
abdomen and femur length (estimated weight) and when measured
as increase in the abdominal circumference.
Secondly, placental weight was identified as a significant
independent determinant both for birthweight and for fetal
growth in third trimester. The latter finding was valid both for
the abdominal circumference and for estimated fetal weight. The
present study also confirms that parity, BMI, weight gain and
Table 2. Determinants for birthweight-for-gestational age Z-scores*. Results from univariate and multiple linear regression.
Model 1 (n=892) Model 2 (n=883)
Unadjusted B 95% CI p-value Adjusted B 95% CI p-value Adjusted B 95% CI p-value
Maternal age (years) 0.015 20.001–0.03 0.065 0.00 20.02–0.02 0.98 0.01 20.02–0.004 0.17
Parity (P1 vs P0) 0.49 0.37–0.61 ,0.001 0.46 0.33–0.59 ,0.001 0.36 0.25–0.47 ,0.001
BMI visit 1 0.06 0.05–0.08 ,0.001 0.048 0.03–0.06 ,0.001 0.018 0.004–0.03 0.012
Weight gain (kg) visit 1–4 0.05 0.03–0.07 ,0.001 0.06 0.04–0.08 ,0.001 0.036 0.02–0.05 ,0.001
Fasting plasma glucose visit
3 (mmol/l)
0.51 0.37–0.65 ,0.001 0.33 0.18–0.48 ,0.001 0.22 0.09–0.34 ,0.001
Placental weight (100 g) 0.41 0.38–0.44 ,0.001 0.39 0.35–0.42 ,0.001
*Z-scores according to Norwegian references (15).
Model 1: adjusted for maternal characteristics (age, parity, BMI, weight gain and fasting plasma glucose).
Model 2: adjusted for maternal characteristics (age, parity, BMI, weight gain, fasting plasma glucose) and placental weight.
doi:10.1371/journal.pone.0039324.t002
Table 3. Biometric ultrasound measurements.
Head circumference
(mm)
Abdominal circumference
(mm) Femur length (mm)
Estimated fetal
weight (g)
Estimated fetal
weight (percentile)
Gest.
weeks n Mean (SD) z-score* n Mean (SD) z-score* n Mean (SD) z-score* n Mean (SD) n Mean (SD)
30232
(visit 3)
987 288.0 (12.1) 0.15 998 275.7 (16.9) 0.17 984 59.3 (3.2) 0.44 975 1875.0 (248.2) 968 52.0 (25.0)
36238
(visit 4)
943 321.6 (11.6) 20.19 952 331.6 (19.9) 0.09 941 70.5 (3.1) 0.64 928 2960.0 (355.2) 918 47.3 (26.6)
D visit 324 910 33.6 (12.7) 20.34 930 55.9 (18.1) 20.08 907 11.2 (3.5) 0.20 890 1085.0 (318.9) 877 24.7 (23.1)
Ultrasound measurements of fetal head circumference, abdominal circumference and femur length measured at two times in the third trimester. Fetal growth was
calculated as the difference between measurements at gestational weeks 30–32 and 36–38, respectively.
N varies due to missing numbers.
Measurements of head circumference, abdominal circumference and femur length are given in mm and reported as means and SD.
*Z-scores calculated according to Norwegian referance charts (19).
The differences between visit 3 and visit 4 are given as differences in mm or grams and as difference in z-scores or percentiles.
doi:10.1371/journal.pone.0039324.t003
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accordance with several previous studies [2,6].
There is accumulating evidence that the nutritional state of the
pregnant women at the start of pregnancy is important for several
measures of pregnancy outcome, including birthweight [21]. BMI
at the beginning of pregnancy may be considered as a surrogate
for the nutritional status of the mother. BMI has been shown to be
a predictor of large for gestational age neonates (LGA) in several
studies including the HAPO-study [7]. In the current study BMI
was found to be an independent determinant also of fetal growth in
third trimester. BMI is an index consisting of both height and
weight, and is associated with a number of more specific biological
variables including genetic, nutritional and endocrine factors that
all may affect fetal growth. In particular substances released from
the maternal adipose tissue may affect fetal growth either directly
or via modification of placental functions. In the current study we
did not aim to identify effects of specific factors associated with
BMI on fetal growth, except glucose. We have previously,
however, reported that interleukin -1 receptor antagonist (IL1-
Ra) is a determinant of birthweight [22]. IL1-Ra is one of the
factors released from adipose tissue [23].
Weight gain during pregnancy is related to fetal growth. Low
weight gain is associated with small for gestational age neonates
(SGA) [24], and high weight gain with birthweight above 4200
and 4500 grams as well as LGA [2,25]. Here we showed that
weight gain also was an independent determinant of third
trimester growth.
Parity was identified as a determinant for fetal growth. It is well
described that parity influences birthweight. The magnitude of
reduced birthweight is about 200 g for the first born child [26].
We showed that fetal growth in third trimester was influenced by
the parity of the mother. The effect of parity might be linked to the
capacity of the spiral arteries to fully dilate or be invaded by
trophoblasts which differ between first and subsequent pregnancies
[27]. The concept that growth pattern differs between the first and
a later born child may be illustrated by data suggesting that truncal
obesity is more common in the first born child and that firstborn
carries a higher metabolic risk in early adulthood [28,29].
Fasting plasma glucose measured in third trimester was
significantly associated with birthweight in our study. Since
transport of glucose is dependent on the maternal-fetal gradient
across the placenta, we expected fasting glucose in third trimester
to play an important role for fetal growth measured during the
period of rapid fetal growth in third trimester. We found, however,
that maternal fasting glucose in week 30–32 failed to reach
statistical significance. This finding may apparently be inconsistent
Table 4. Determinants for fetal growth in third trimester.
Model 1 (n=847) Model 2 (n=829)
Unadjusted B 95% CI p-value Adjusted B 95% CI p-value Adjusted B 95% CI p-value
Maternal age (years) 0.11 20.29–0.50 0.6
Parity (P1vs P0) 4.35 1.29–7.41 0.005 4.73 0.16–8.07 0.006 3.9 0.75–7.0 0.015
BMI visit 1 0.71 0.32–1.11 ,0.001 0.64 0.23–1.06 0.002 0.49 0.08–0.89 0.02
Weight gain (kg) 0.62 0.17–1.07 0.007 0.70 0.24–1.16 0.003 0.60 0.15–1.06 0.01
Fasting glucose
(mmol/l)
2.55 20.89–5.99 0.15
Placental weight (100g) 2.60 1.60–3.60 ,0.001 2.08 1.03–3.13 ,0,001
Results from univariate and multiple linear regression using difference in estimated weight percentiles* as fetal growth (Dp4–p3).
*Estimated fetal weight percentiles according to Norwegian reference charts (17).
Model 1: adjusted for maternal characteristics (maternal age, parity, BMI, weight gain and fasting plasma glucose).
Model 2: adjusted for maternal characteristics (maternal age, parity, BMI, weight gain and fasting plasma glucose) and placental weight.
doi:10.1371/journal.pone.0039324.t004
Table 5. Determinants for fetal abdominal growth in third trimester.
Model 1 (n=872) Model 2 (n=852)
Unadjusted B 95% CI p-value Adjusted B 95% CI p-value Adjusted B 95% CI p-value
Maternal age (years) 0.002 20.01–0.02 0.77
Parity P1 vs P0 0.17 0.07–0.27 0.001 0.18 0.07–0.29 0.001 0.14 0.034–0.24 0.009
BMI visit 1 0.023 0.01–0.04 0.001 0.022 0.005–0.03 0.002 0.014 0.00–0.028 0.048
Weight gain (kg) 0.02 0.005–0.04 0.009 0.026 0.008–0.04 0.001 0.021 0.005–0.036 0.008
Fasting glucose
(mmol/l)
0.13 0.01–0.24 0.031 0.44 –0.08–0.17 0.48 0.016 –0.11–0.14 0.8
Placental weight
(100 g)
0.11 0.08–0.14 ,0.001 0.095 0.06–0.13 ,0.001
Results from univariate and multiple linear regression using difference in abdominal circumference in z-scores* as abdominal growth (ACDz).
*Z-scores according to Norwegian reference charts (19).
Model 1: adjusted for maternal characteristics (maternal age, parity, BMI, weight gain and fasting plasma glucose).
Model 2: adjusted for maternal characteristics (maternal age, parity, BMI, weight gain and fasting plasma glucose) and placental weight.
doi:10.1371/journal.pone.0039324.t005
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categories including the HAPO-study. However, the current and
previous findings are not necessarily contradictory. The lack of
effect of glucose on fetal growth could be explained by considering
the body composition of the baby. We measured fetal growth as
either change in a composite variable consisting of fetal head,
abdomen and femur or just change in the abdominal circumfer-
ence. Fasting glucose had no effect on neither of these endpoints.
We therefore speculate that the effect of hyperglycaemia
preferentially leads to deposition of fat in the extremities and the
thoracic truncus of the fetus and hence will not be captured by
either measuring fetal growth as abdominal circumference or
estimated fetal weight as calculated in the present study, but will be
reflected in the birthweight. This notion is supported by pre-
liminary data showing that caliper based skin fold measures of
arms, legs and the sub scapular area were significantly correlated
with fasting plasma glucose. In fact, the association remained
significant after adjusting for the other maternal determinants used
in our study (data not shown).
Placental weight has been shown to be closely correlated with
birthweight in large studies [13]. In our study placental weight and
birthweight were also strongly correlated (r=0.67, p,0.001) and
we also showed that placental weight was independently associated
with fetal growth in third trimester. This finding is not surprising,
placenta being responsible for all maternal-fetal oxygen and
nutrient exchange. However, in the large majority of previous
studies of determinants of birthweight, including the HAPO-study,
placental weight has not been considered. Placenta exhibits a linear
growth throughout pregnancy [30,31].Thus, given that placental
weight reflects functional properties, final placental weight should
also provide information about placental function earlier in
pregnancy. Placental growth includes both lateral growth of the
chorionic disc and thickness of placenta. Lateral growth reflects
the uterine area covered by the placenta and hence how many
spiral arteries are potential suppliers of the placenta. The thickness
of the placenta reflects the arborization of the villous tree and
vascular nutrient exchange surface [32].
Placental volume can be estimated by ultrasound. In a study by
Thame et al placental volume was estimated by ultrasound at
week 20 and found to be positively correlated with placental
weight at birth (r=0.46, p,0.001) [33]. Maternal characteristics
have been shown to influence growth of placenta and also various
dimensions of placental growth. In a study of more than
24000 placentas in the US the relationships between maternal
characteristics, placental growth measures and birthweight were
explored. Placental weight alone accounted for 36.5% of birth-
weight variation, whereas only 13.9% of birthweight variation
could be explained by maternal characteristics like age, parity,
height and weight, cigarette use, ethnicity and socio-economic
status [13]. Our data gave similar results; the selected variables
parity, BMI, weight gain and fasting glucose explained 16% of
variation in birthweight, whereas placental weight alone explained
39% of variation in birthweight (data not shown).
In a study of the US cohort referred to above, maternal
characteristics and associations to three dimensions of placental
growth (placental weight, thickness and chorionic plate area) were
studied [34]. Pre pregnancy BMI and weight gain were identified
as predictors of hypertrophy of all three dimensions of placental
growth. Thus, currently available data indicate that effects of BMI
and weight gain on birthweight and fetal growth at least partly is
mediated through an effect on placental properties, including
growth. This notion is supported by the fact that BMI had an
independent effect on placental weight (p,0.001, data not shown),
but also on birthweight with placental weight as a covariate. A
better estimation of the magnitude of direct and indirect effects
may be obtained by a path analysis [22]. There are several possible
biological reasons for the reduced effects of the maternal
characteristics on birthweight when placental weight is included
in the models. The selected maternal characteristics may exert
their effects on growth by affecting transplacental transport.
Transplacental transport is affected by blood flow both on
maternal and fetal side. Furthermore, the number and efficiency
of placental transport proteins may also be influenced by maternal
factors. In addition, it can not be excluded that placental
production of growth factors may be affected.
Strengths and Limitations
The strengths of this study are the well characterised cohort in
terms of maternal characteristics and the longitudinal design
including serial ultrasound measurements. This allowed us to
explore the associations between several maternal characteristics
and intrauterine fetal growth as the endpoint, in addition to the
more conventional way of measuring fetal growth as birthweight.
We did not obtain weight of the placenta after being trimmed for
membranes and umbilical cord. There is however a close
correlation (r=0.98) between the weight of trimmed and un-
trimmed placentas [35].
It can be argued whether conditional growth percentiles should
be used. In separate analyses we calculated conditional growth
between visit 3 and visit 4 and obtained conditional percentiles
which were used in the linear regression model (results not shown).
Although the regression coefficients were different, the variables
that remained statistically significant in the multiple model were
exactly the same as using unconditional growth percentiles. We
acknowledge that using conditional growth gives an interesting
and probably more correct understanding of fetal growth.
However, we have experienced that the concept of conditional
growth represents a challenge to understand. We therefore chose
to use the unconditional percentiles as the results are the same in
the current work.
Conclusion
Maternal metabolic factors including BMI, weight gain and
glucose values are modifiable determinants of fetal growth.
Avoiding abnormal fetal growth may reduce the number of
newborns experiencing adverse outcome both in short and long
term. However, our findings indicate that placental weight
markedly modifies the effect of determinants on both birthweight
and fetal growth parameters. The differential effect of third
trimester glucose on birthweight and growth parameters illustrates
that birthweight and fetal growth are not identical entities in terms
of their determinants.
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